Want to join the conversation?
Jacksonville, Florida-based $SMRT said it is revising its preliminary financial results for 1Q16 previously released on May 19, 2016. The company has increased SG&A expenses by $675,000 and decreased net income by $419,000 or $0.01 per diluted share. $SMRT's revised net income is now $13.3MM or $0.29 per diluted share.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?